Share chart ARS Pharmaceuticals, Inc.
Extended chart
Simple chart
About
ARS Pharmaceuticals, Inc., биофармацевтическая компания, разрабатывает методы лечения пациентов и родителей, страдающих тяжелыми аллергическими реакциями. Компания разрабатывает neffy, безыгольный интраназальный назальный спрей с низкой дозой адреналина для пациентов и лиц, осуществляющих уход за ними, с аллергическими реакциями I типа, включая анафилаксию. Компания была основана в 2015 году и базируется в Сан-Диего, штат Калифорния.
P/S | 90.16 |
---|---|
P/BV | -114.44 |
EV/EBITDA | -0.2506 |
EBITDA | -0.0225 |
Цена ао | 8.74 |
Сайт | https://ars-pharma.com |
Выручка | 0.0178 |
ISIN | US82835W1080 |
Число акций ао | 0.09522 млрд |
Валюта | usd |
IPO date | 2020-12-04 |
Sector | Health Care |
Industry | Biotechnology |
Валюта отчета | usd |
Change price per day: | 0% (14.52) |
---|---|
Change price per week: | +6.3% (13.66) |
Change price per month: | +9.17% (13.3) |
Change price per 3 month: | +28.04% (11.34) |
Change price per half year: | +60.26% (9.06) |
Change price per year: | +295.64% (3.67) |
Change price per 3 year: | +38.68% (10.47) |
Change price per year to date: | +221.95% (4.51) |
|
Underestimation
|
Efficiency
|
|||||||||||||||||||||||||||||||||||||
Dividends
|
Debt
|
Growth impulse
|
Institutions | Volume | Share, % |
---|---|---|
Deerfield Management Company, L.P. (Series C) | 11077927 | 11.69 |
Orbimed Advisors LLC. | 8740887 | 9.22 |
FMR, LLC | 5088253 | 5.37 |
SR One Capital Management, LP | 4012903 | 4.23 |
Rubric Capital Management LP | 3480712 | 3.67 |
RA Capital Management, L.P. | 3009678 | 3.18 |
K2 Principal Fund, L.P. | 2686490 | 2.83 |
Baker Brothers Advisors, LLC | 2006451 | 2.12 |
Nextech Invest Ag | 1910029 | 2.02 |
Vanguard Group Inc | 1697637 | 1.79 |
ETF | Share, % | Profitability for 1 year, % | Dividends, % |
---|---|---|---|
Avantis U.S Small Cap Equity ETF | 0.0824 | 27.774101036841 | 1.68271 |
Avantis U.S. Equity ETF | 0.00092 | 32.224830464267 | 1.59151 |
ProShares Ultra Nasdaq Biotechnology | 0.09046 | 51.697637072723 | 0.85651 |
Dimensional U.S. Core Equity 2 ETF | 0.00029 | 30.755198832543 | 1.47098 |
Dimensional US Core Equity Market ETF | 0.00016 | 30.983243755928 | 1.40618 |
Dimensional U.S. Equity ETF | 0.00008 | 31.530984204131 | 1.3557 |
Invesco Dorsey Wright SmallCap Momentum ETF | 0.59575 | 33.912466843501 | 0.61241 |
Fidelity MSCI Health Care Index ETF | 0.00716 | 13.390080209527 | 1.46057 |
Goldman Sachs ActiveBeta US Small Cap Equity ETF | 0.05874 | 31.359936575053 | 1.41955 |
ProShares Hedge Replication ETF | 0.00422 | 5.9237999659878 | 1.47892 |
Humankind US Stock ETF | 0.00433 | 18.809430395549 | 1.99919 |
Invesco Nasdaq Biotechnology ETF | 0.13872 | 28.578975171685 | 0.8565 |
iShares Micro-Cap ETF | 0.18438 | 36.318555985322 | 1.54048 |
iShares Russell 2000 Growth ETF | 0.05387 | 38.042556988 | 0.6026 |
iShares Russell 3000 ETF | 0.00174 | 32.57283798366 | 1.43482 |
Direxion Daily S&P Biotech Bull 3x Shares | 0.10101 | 4067.9190751445 | 0.25924 |
Schwab U.S. Small-Cap ETF | 0.01776 | 34.281650071124 | 1.51433 |
Schwab U.S. Broad Market ETF | 0.00128 | 32.5 | 1.43354 |
iShares MSCI USA Small-Cap Min Vol Factor ETF | 0.09976 | 29.310344827586 | 1.66828 |
SPDR Portfolio MSCI Global Stock Market ETF | 0.00051 | 23.600605143722 | 2.19607 |
ProShares UltraPro Russell2000 | 0.01571 | 89.821266282945 | 1.47873 |
Vanguard U.S. Momentum Factor ETF | 0.06 | 45.845704753962 | 1.05834 |
Vanguard Russell 3000 ETF | 0 | 31.87314172448 | 1.43817 |
Vanguard Russell 2000 Growth ETF | 0.05 | 39.350070246167 | 0.60264 |
Vanguard Russell 2000 ETF | 0.02 | 35.648084105685 | 1.48801 |
Principal Healthcare Innovators ETF | 0.13757 | 618.4964157054 | 0.8416 |
Future Tech ETF | 0.13757 | 426.33969118983 | 0.8416 |
Head | Job title | Payment | Year of birth |
---|---|---|---|
Mr. Richard Lowenthal M.B.A., M.S., MSMSEL | Founder, President, CEO & Director | 908.83k | 1966 (58 years) |
Dr. Sarina Tanimoto M.B.A., M.D. | Co-Founder & Chief Medical Officer | 748.97k | 1969 (55 years) |
Mr. Eric Karas | Chief Commercial Officer | 618.61k | 1973 (51 year) |
Dr. Robert Bell Ph.D. | Co-Founder & Chief Science Officer | N/A | |
Ms. Kathleen D. Scott CPA | Chief Financial Officer | N/A | |
Mr. Brian T. Dorsey M.S. | Chief Operations Officer | N/A | 1969 (55 years) |
Mr. Alexander A. Fitzpatrick Esq. | Chief Legal Officer & Secretary | N/A | 1967 (57 years) |
Mr. Daniel Relovsky | Senior Vice President of Marketing | N/A | |
Mr. Justin Chakma | Chief Business Officer & Secretary | N/A | 1990 (34 years) |
Mr. Harris Kaplan M.B.A. | Executive Vice President of Commercial Strategy | N/A | 1952 (72 years) |
Address: United States, San Diego. CA, 11682 El Camino Real - open in Google maps, open in Yandex maps
Website: https://ars-pharma.com
Website: https://ars-pharma.com